Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating safety, tolerability, and immunogenicity of V114 in healthy adults and infants (Phase 1/2) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• V114 (15-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-17